Jeena Sikho Lifecare Limited announced that its board of directors approved a significant loan agreement with its wholly owned subsidiary during a meeting held on January 21, 2026. The board meeting, which commenced at 5:30 PM and concluded at 6:00 PM, resulted in the approval of an unsecured loan facility worth AED 7.53 million.

Loan Agreement Details

The loan agreement was executed with Jeena Sikho International LLC, a wholly owned subsidiary of the company, to provide financial assistance for business and operational requirements. The transaction is structured as a related party transaction conducted on an arm's length basis.

Transaction Structure and Terms

The loan facility carries an interest rate of 8.50% per annum, calculated on a simple interest basis on the outstanding principal amount. This interest rate applies uniformly to every tranche disbursed under the agreement. The loan tenure spans five years from the date of the first disbursement, providing the subsidiary with medium-term financial support.

The company holds 100% equity shareholding in Jeena Sikho International LLC, making this transaction a related party arrangement. The board confirmed that the loan agreement was structured and executed on an arm's length basis, ensuring compliance with regulatory requirements for related party transactions.

Regulatory Compliance and Disclosures

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided comprehensive details as required under the listing regulations and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Compliance Matters Addressed

The board also acknowledged fines imposed by stock exchanges for previous non-compliance issues. The National Stock Exchange of India Limited imposed a fine dated December 31, 2025, while BSE Limited imposed a fine dated December 15, 2025, both for non-compliance with Regulation 29 of the SEBI listing regulations.

The company has paid both fines in full and implemented measures to strengthen its compliance systems going forward. This demonstrates the company's commitment to maintaining regulatory compliance and improving its governance framework.

Corporate Information

Jeena Sikho Lifecare Limited operates over 120 Ayurveda clinics and hospitals, positioning itself in the traditional healthcare sector. The company is registered in Punjab with its registered office located in Zirakpur and corporate office in New Delhi. The loan agreement supports the expansion and operational requirements of its international subsidiary, facilitating the company's business growth initiatives.

Jeena Sikho Lifecare has received board approval for a strategic acquisition in the UAE healthcare market through its wholly-owned subsidiary. The company's subsidiary, Jeena Sikho International LLC, has obtained formal approval from its Board of Directors to acquire a majority stake in an Abu Dhabi-based Ayurveda healthcare company, marking a significant step in the company's international expansion strategy.

Board Approval and Acquisition Structure

Jeena Sikho International LLC's Board of Directors has approved the acquisition proposal for a 51% equity stake in Back to Roots Ayurveda by Dr. Shyam LLC. The formal board approval represents a crucial milestone in the transaction process, moving the acquisition closer to completion.

Target Company Profile

Back to Roots Ayurveda is a trusted Ayurveda healthcare brand in the United Arab Emirates that delivers authentic, doctor-led Ayurvedic care through a modern, patient-centric approach. The company combines classical Ayurvedic wisdom with contemporary clinical standards, making traditional healing relevant for today's lifestyle. It operates as a fast-growing healthcare business in the UAE, specializing in traditional Kerala treatments and Panchakarma therapies.

Financial Performance Track Record

The target company, incorporated on December 15, 2023, has demonstrated exceptional growth in its operational history:

Strategic Business Rationale

The board-approved acquisition forms part of Jeena Sikho Lifecare's comprehensive strategy to strengthen its footprint in the Ayurveda and wellness segment while exploring strategic business opportunities in international markets. The acquisition will enable the group to benefit from the target entity's existing operations, experience, and established market presence in the UAE healthcare sector.

Corporate Structure and Regulatory Framework

Upon completion of the acquisition, Back to Roots Ayurveda by Dr. Shyam LLC will become a subsidiary of Jeena Sikho International LLC and consequently a step-down subsidiary of Jeena Sikho Lifecare Limited. The transaction does not fall within related party transactions, and no governmental or regulatory approvals are required for the acquisition. The transaction will be executed through a Share Purchase Agreement between the parties, which is yet to be finalized.

The board-approved acquisition represents Jeena Sikho Lifecare's commitment to expanding its presence in the international Ayurveda and wellness market, leveraging the growing demand for traditional healthcare solutions in the Middle East region.